Toggle light / dark theme

Targeted Multidomain Treatment for Mild Traumatic Brain Injury: A Randomized Clinical Trial

RCT: Among adults with mTBI, targeted multidomain interventions and usual care behavioral management resulted in similar improvements in overall symptom severity and patient-perceived recovery over 4 weeks.


Question Is a targeted multidomain (T-MD) intervention more effective than a standardized behavioral management intervention in adults with mild traumatic brain injury (mTBI)?

Findings In this randomized clinical trial of 162 patients, both the T-MD and behavioral management groups experienced similar improvements in mTBI symptom severity and perceived improvement in primary outcomes over 4 weeks.

Meaning The findings suggest that both T-MD and behavioral management are effective for improving global mTBI symptoms.

The transcriptional regulator BRD4 is an emerging target for cancer and other diseases in adults and children; however, its role in development is not well understood

David B. Frank & team now report BRD4 regulates gene expression and cell differentiation of lung endodermal progenitors into epithelial cells of the lung airways:

The figure shows mutant lungs exhibit fewer and dilated airways with diminished SOX2 expression in distal airways in addition to the formation of cystic distal airway structures.


1Department of Pediatrics, Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, and.

2CHOP Cardiovascular Institute, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

3Penn Cardiovascular Institute.

4Penn-CHOP Lung Biology Institute, and.

CRISPR the emergence of TIGR systems Rewriting DNA

Delve into the groundbreaking world of CRISPR gene editing – a technology rapidly reshaping medicine and offering unprecedented hope for treating previously incurable diseases. This video explores the remarkable journey from basic scientific curiosity about bacterial defense mechanisms to the first-ever personalized gene therapies being administered in Germany and beyond.

Discover how scientists uncovered CRISPR, an ancient bacterial immune system that functions as a precise molecular “cut-and-paste” tool for DNA. Learn about the astonishing speed at which this discovery transitioned from laboratory research to clinical applications, culminating in FDA approval of treatments for sickle cell disease and beta thalassemia – conditions once considered devastatingly difficult to manage.

We’ll examine the details of these revolutionary therapies, including how they work to correct genetic defects and provide lasting relief for patients. Beyond current successes, explore the exciting potential of CRISPR to address a wide range of inherited disorders, from hereditary angioedema to various cancers.

The video highlights the extraordinary case of KJ, an infant who received a custom-designed CRISPR base editing therapy to treat a rare metabolic disorder – demonstrating the feasibility of truly personalized medicine tailored to individual genetic profiles. Understand how this breakthrough compresses years of research into mere months, paving the way for treating countless other rare diseases.

Finally, look ahead to the future with the emergence of TIGR systems, an even more advanced class of gene-editing tools discovered in viruses that infect bacteria. These next-generation technologies promise enhanced precision, broader targeting capabilities, and potentially safer therapeutic applications. Join us as we unpack this complex science and reveal how fundamental research continues to unlock the secrets of life and offer hope for a healthier future.

#genetherapy.

Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment

Lodi et al. create a pan-cancer single-cell atlas characterizing immune cell heterogeneity within the tumor microenvironment (TME). They identify 70 shared cell subtypes, some of which are spatially co-localized to form two distinct immune reactive TME hubs. Both hubs associate with improved checkpoint immunotherapy outcome across different cancer types.

‘Tour de force’ mouse study shows a gut microbe can promote memory loss

Scientists have plenty of ideas about why aging impairs memory. Reductions in blood flow in the brain, shrinking brain volume, and malfunctioning neural repair systems have all been blamed. Now, new research in mice points to another possible culprit: microbes in the gut.

In a new study, scientists show how a bacterium that is particularly common in older animals can drive memory loss. This microbe makes compounds that impair signaling along neurons connecting the gut with the brain, dampening activity in brain regions associated with learning and memory, the team found.


Research suggests the microbiome may contribute to cognitive decline—but its relevance in humans is unclear.

Ageing promotes metastasis via activation of the integrated stress response

Ageing reprograms the evolutionary trajectory of KRAS-driven lung adenocarcinoma, limiting primary tumour growth while promoting metastatic dissemination through epigenetic activation of the integrated stress response, and a therapeutic opportunity in older patients is revealed.

Cool Qubits Make Faster Decisions

Classical machine learning has benefited several physics subfields, from materials science to medical imaging. Implementing machine-learning algorithms on quantum computers could expand their use to more complex problems and to datasets that are inherently quantum. Nayeli Rodríguez-Briones at the Technical University of Vienna and Daniel Park at Yonsei University in South Korea have now proposed a thermodynamics-inspired protocol that could make quantum machine-learning techniques more efficient [1].

In one common classical machine-learning task, a system is trained on a known dataset and then challenged to classify new data. Its output quantifies both the classification and that classification’s uncertainty. Once the system’s parameters are fixed, evaluating the same data yields the same output. In contrast, the output of a quantum machine-learning algorithm is read out as binary measurements of qubits, which are inherently probabilistic. Because a single measurement provides only limited information, the computation must be repeated many times.

Rodríguez-Briones and Park recognized that how clearly a quantum computer reveals its output is determined by entropy. When the readout qubit is highly polarized—strongly favoring one outcome—its entropy is low. Few repetitions are needed to obtain a firm result. An unpolarized, high-entropy readout qubit returns both states more evenly, meaning more repetitions are required. The researchers showed that the readout qubit’s polarity can be increased by transferring its entropy to ancillary qubits, effectively cooling one while warming the others. Between runs, the ancillary qubits are reset by coupling them to a heat bath. Crucially, this entropy transfer affects the readout qubit’s degree of polarization without changing the encoded decision. The upshot: A given result can be arrived at with fewer repetitions.

/* */